Global Process Analytical Technology Market Assessment, By Product [Analyzers, Sensors and Probes, Samplers, Software and Services], By Technology [Spectroscopy, Chromatography, Capillary Electrophoresis, Particle Size Analysis, Others], By Monitoring Method [In-Line, At-Line, On-Line, Off-Line], By End-user [Pharmaceutical Manufacturers, Biopharmaceutical Manufacturers, Contract Research Organizations (CROs)/CDMOs], By Region, Opportunities and Forecast, 2017-2031F

Global process analytical technology market is projected to witness a CAGR of 10.45% during the forecast period 2024-2031, growing from USD 5.01 billion in 2023 to USD 11.10 billion in 2031. The rising demand for quality control, real-time data, and efficient production processes in pharmaceuticals, food, and chemicals drives the market for process analytical Technology (PAT). Also, increased regulatory standards, technological advancements in analytics, and reduced operations costs drive the market's growth during the forecast period.  

Process Analytical Technology (PAT) is a regulatory framework by the FDA for better process understanding, control, and quality during manufacture. Process analytical technology (PAT) helps manufacturers establish constant quality and efficiency and reduce waste by incorporating real-time monitoring, analysis, and feedback systems. It measures critical quality attributes during production processes so that adjustments can promptly be made to ensure the quality of final products and compliance with regulations. As industries focus on precision, efficiency, and sustainability, PAT has emerged as an essential tool that supports digital transformation and smart manufacturing initiatives.

Investments and technological advancements like AI are changing the face of the process analytical technology (PAT) market, allowing for expedited drug discovery and development. For instance, in December 2023, Sanofi-Aventis Groupe made an investment of USD 140 million in Aqemia to accelerate drug discovery using artificial intelligence. This investment represents a growing trend toward faster and more streamlined pipelines, an important strategic move in optimizing drug development. It aims to minimize costs and reduce timelines for bringing new therapies into the market.

Increased Investments in Drug Development Processes Promote Market Growth

Investment in drug development processes has driven the growth of the process analytical technology market by incorporating real-time analytics into the production process. This allows for accurate monitoring of critical quality attributes during the production process. Better funding for advanced PAT tools supports continuous process verification and ensures regulatory compliance. Additionally, such investments drive the development of new biopharmaceuticals that require advanced analytical techniques for process optimization. In addition to accelerating the drug development timeline, such targeted funding would simultaneously enhance process efficiency through cost reduction and product quality improvement. PAT solutions will be adopted faster across the industry. 

For instance, in October 2024, Eli Lilly and Company invested USD 4.5 billion to develop the Lilly Medicine Foundry in Indiana's LEAP Research District. The center will serve as a dual-purpose facility that advances drug production research and expands clinical trial manufacturing. This investment will also boost demand for process analytical technology because it helps to bring about breakthroughs in challenging diseases.

Pharma 4.0 to Drive Market Growth

Pharma 4.0 refers to the implementation of advanced technologies that have revolutionized the manufacturing landscape. It has challenged the established drug development methods. Advancements in technologies such as real-time data analytics, artificial intelligence, and machine learning significantly fuel the growth of the process analytical technology market. Such innovations ensure continuous monitoring and optimization of manufacturing processes, thus upgrading the quality of the final product and reducing time-to-market. Companies are spending more on automation and smart sensor technologies to improve the control and compliance of a process. Apart from this, the integration of IoT devices improves data collection and analysis, which enhances efficiency. By investing in such advanced technologies, organizations want to improve operational performance and meet rigorous regulatory requirements, making themselves competitive in the ever-changing pharmaceutical and manufacturing landscapes.

For instance, in May 2023, Google Cloud unveiled two AI-driven solutions at the Bio-IT World Conference to speed up drug discovery and precision medicine across the globe. Cerevel Therapeutics, LLC, Colossal Biosciences Inc., and Pfizer Inc. accelerate drug discovery with new AI-powered solutions from Google Cloud. Such Pharma 4.0 technologies influence market growth through improved research designs for treatment.

Continuous Manufacturing to Fuel Market Growth

In January 2023, WuXi STA, a subsidiary of WuXi AppTec, inaugurated its first continuous manufacturing line for oral solid drugs at its Wuxi, China facility. This advanced line, globally compliant with cGMP, incorporates PAT for monitoring the blend uniformity in real-time, enhances the quality of the product, and hastens the drug development process. Its usage in PAT here showcases its role in a continuous manufacturing line and augments the market growth. For instance, in January 2023, WuXi AppTec (Shanghai) Co., Ltd. established its first continuous manufacturing line for oral solid drugs at its Wuxi, China facility. This advanced line, globally compliant with cGMP, incorporates PAT for monitoring the blend uniformity in real-time, enhances the quality of the product, and hastens the drug development process. Its usage in PAT here actually showcases its role in a continuous manufacturing line and thereby augments the market growth.

Spectroscopy Segment Dominating Process Analytical Technology Market

The spectroscopy segment currently dominates the process analytical technology market. Techniques like near-infrared (NIR), Raman, and mass spectroscopy are most applied because they can provide fast, non-destructive analysis in real-time, which is critical to continuous manufacturing. Spectroscopy allows critical parameters like composition and chemical properties to be monitored in detail for high-quality products and regulatory compliance. Its versatility across pharmaceuticals and food processing industries makes it indispensable in the modern applications of PAT. As continuous processes continue to gain popularity, the market should continue increasing demand for spectroscopy-based PAT solutions, making it a leader in the market.

For instance, in April 2024, Bruker Corporation introduced breakthrough magnet technology and analytical instrumentation that will support nuclear magnetic resonance (NMR) application in academia as well as in biopharma drug discovery and development, including PAT. The whole setup changes the production process of active pharmaceutical ingredients (APIs) by enabling distribution and on-demand manufacturing. The use of PAT along with AI in API manufacturing enhances safety, reduces environmental impact, and reduces costs while showing that PAT plays a vital role in market growth.   

North America Dominates Process Analytical Technology Market Share

North America holds the largest market share for PAT owing to the most significant pharmaceutical and biotechnology companies, such as Pfizer Inc. and Johnson & Johnson Services, Inc., which are based in this region and invest heavily in PAT to maintain quality and enhance the overall process. In addition, advanced technological infrastructure and significant investment in R&D support PAT system integration into the regional market, which provides a stimulus for regional leaders. An accelerated adoption rate of new technologies, such as AI and digital twins, which strengthens process efficiency and compliance while leading North America in PAT market shares, further supports the region's position. The increasing need for advanced quality control in biopharmaceutical companies in the region has led companies to invest in innovations and expand their portfolios.

For instance, in October 2023, LumaCyte, Inc. introduced the compact Radiance miniaturized instrument for biomanufacturing and quality control. This miniature device can characterize cells in real time and be label-free to help manufacture complex biotherapeutics in an enhanced manner. The application of process analytical technology enhances the efficiency of production and the product's success, thereby driving the market's growth for advanced therapy analytics.

Download Free Sample Report

Future Market Scenario (2024-2031F)

Process analytical technology (PAT) is expected to grow significantly in the coming years since drug discovery and gene therapy will continue to be investable. The increasing interest in Pharma 4.0, real-time monitoring, and data-driven decisions will further accelerate the pace of current efficiency and quality in pharmaceutical manufacturing processes.

Moreover, adopting AI-enabled digital twins (DTs) will revolutionize biopharmaceutical manufacturing by enhancing process analytical technology (PAT). Virtual models increase efficiency and product quality using real-time data, predicting results that allow for closed-loop control. Industry 4.0 technologies will lead to innovation and operational excellence as AI-driven DTs dictate the industry's approach forward. Thus, this is the most critical tool for the PAT market's future growth.

Report Scope

“Process Analytical Technology Market Assessment, Opportunities and Forecast, 2017-2031F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of the global process analytical technology market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecast between 2024 and 2031. Additionally, the report profiles the leading players in the industry, mentioning their respective market share, business models, competitive intelligence, etc.

Report Attribute	Details
Base Year of the Analysis	2023
Historical Period	2017-2022
Forecast Period	2024-2031
Projected Growth Rate	CAGR of 10.45% between 2024 and 2031
Revenue Forecast in 2031	USD 11.10 billion
Segments Covered	Product, Technology, Monitoring Method, End-user
Regions Covered	North America, Europe, South America, Asia-Pacific, Middle East and Africa
Key Companies Profile	Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Shimadzu Corporation, Bruker Corporation, Danaher Corporation, PerkinElmer, Inc., Mettler-Toledo International Inc., Waters Corporation, ABB Ltd., Carl Zeiss AG
Customization Scope	15% free report customization with purchase
Pricing and Purchase Options	Avail the customized purchase options to fulfill your precise research needs
Delivery Format	PDF and Excel through email (subject to the license purchased)

In the report, the global process analytical technology market has been segmented into the following categories: 

• By Product
  • Analyzers
  • Sensors and Probes
  • Samplers
  • Software and Services
• By Technology
  • Spectroscopy
    • NIR (Near Infrared) Spectroscopy
    • Raman Spectroscopy
    • NMR (Nuclear Magnetic Resonance) Spectroscopy
    • Mass Spectroscopy
    • Others
  • Chromatography
    • Liquid Chromatography
    • Gas Chromatography
  • Capillary Electrophoresis
  • Particle Size Analysis
  • Others
• By Monitoring Method
  • In-Line
  • At-Line
  • On-Line
  • Off-Line
• By End-user
  • Pharmaceutical and Biopharmaceutical Manufacturers
  • Contract Research Organizations (CROs) and Contract Development and Manufacturing Organizations (CDMOs)
  • Other End-users
• By Region
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa

Key Players Landscape and Outlook

The key players in the process analytical technology market are focusing on product innovation, geographic expansion, and strategic partnerships to enhance service offerings. They focus on integrating advanced technologies such as AI and machine learning in their approaches to maximize efficiency and also enhance performance. The existing competitive landscape features both existing companies and start-ups alike.

In January 2024, Bruker Corporation acquired Tornado Spectral Systems Inc., a Canadian-based developer of process Raman technologies, primarily used for quality control in the pharmaceutical and biotech industries. With over a decade of experience, Tornado will augment Bruker's biopharma process analytical technology (PAT) offerings with reliable Raman solutions along with an experienced team equipped with deep application knowledge.

In June 2023, Thermo Fisher Scientific Inc. acquired MarqMetrix Inc., an advanced in-line process analytical technology (PAT) provider, which enables clients to achieve accurate measurements during the manufacturing process in many industries such as biopharma, pharmaceuticals, oil and gas, and chemicals. This acquisition enhances Thermo Fisher’s portfolio, positioning them as a leader in the market.

In June 2022, Agilent Technologies, Inc. partnered with Merck & Co., Inc. to meet the need for downstream processing for higher process analytical technologies. This partnership will enhance real-time monitoring and automated control of critical process parameters by combining Merck’s bioprocess solutions with Agilent advanced analytical tools. Agilent will be in a better competitive position in the market.

Key Players Operating in the Global Process Analytical Technology Market are:

• Thermo Fisher Scientific Inc. 
• Agilent Technologies, Inc.
• Shimadzu Corporation
• Bruker Corporation
• Danaher Corporation
• PerkinElmer, Inc.
• Mettler-Toledo International Inc.
• Waters Corporation
• ABB Ltd.
• Carl Zeiss AG

Markets and Data’s reports answer the following questions:

• What is the current and future market size of the product/service in question globally or specific to different countries?
• How are the markets divided into different product/service segments and the market size and growth of each segment?
• What is the market potential of different product segments and their investment case?
• How are the markets predicted to develop in the future and what factors will drive or inhibit growth?
• What is the business environment and regulatory landscape specific to the product/service?

If you can't find what you're searching for or have any custom requirements for global process analytical technology market, you may approach our team at info@marketsandata.com